Peek behind the paper: exploring regulatory frameworks in the stem cell industry

Written by RegMedNet

Peek behind the paper: exploring regulatory frameworks in the stem cell industry

In this peek behind the paper, Elizabeth Richardson gives insight into her recent article published in Regenerative Medicine discussing the FDA’s regenerative medicine framework, challenges for regulators and interventions to limit the spread of misinformation. Read the full article, ‘Evaluating the FDA regenerative medicine framework: opportunities for stakeholders’, here>> Could you introduce yourself and tell us a bit about your background? I direct the Health Care Products project at The Pew Charitable Trusts (DC, USA), an independent, non-partisan, non-profit organization dedicated to serving the public interest. As part of our work, we identify specific threats to public health and pursue...

To view the full article, please register now for access

It's completely free